LifeVantage Co. (NASDAQ:LFVN) to Issue $0.04 Quarterly Dividend

LifeVantage Co. (NASDAQ:LFVN) announced a quarterly dividend on Friday, October 25th,Zacks Dividends reports. Shareholders of record on Monday, December 2nd will be paid a dividend of 0.04 per share on Monday, December 16th. This represents a $0.16 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date of this dividend is Monday, December 2nd.

LifeVantage has a dividend payout ratio of 21.3% meaning its dividend is sufficiently covered by earnings.

LifeVantage Price Performance

LifeVantage stock opened at $14.61 on Friday. LifeVantage has a one year low of $5.22 and a one year high of $15.15. The firm has a market capitalization of $182.92 million, a P/E ratio of 45.66 and a beta of 0.84. The business has a fifty day moving average price of $12.89 and a 200-day moving average price of $9.46.

LifeVantage (NASDAQ:LFVN) last issued its earnings results on Tuesday, October 29th. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The business had revenue of $47.21 million during the quarter.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.